看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
7 \/ n5 S) Y+ I- J6 L* {, [1 ] S2 v+ e8 e, F' D1 ?- n, S
; V3 L4 C1 ^5 q+ b+ z& q
Currently available feasibility data for possible combination strategies.
! I/ R( y; w( `' O————————————————————————————————
- b: d7 \ @6 OCombination Feasibility according to preliminary data
3 H0 V+ _) O7 j8 ]' N——————————————————————————————————
1 {. R( V5 \/ s6 JBevacizumab + sorafenib Yes, reduced dose / X% |" L2 s( N. ` g8 L
Bevacizumab + sunitinib† No 7 U% j$ b$ \" h& i/ l
Bevacizumab + temsirolimus Yes
' ]& R0 K+ C. iBevacizumab + everolimus Yes / t- p' X- F/ ^
Sorafenib + sunitinib ? ) u. c/ x; K; d
Sorafenib + temsirolimus Yes, reduced dose
* P- ?' y+ I% M% kSorafenib + everolimus Yes, reduced dose 6 l0 @- X" ?' w8 O( P) ]6 c9 u
Sunitinib + temsirolimus† No - n: X5 e1 x, |) g6 Y* R
Sunitinib + everolimus ? 0 l1 n. H, |: q3 G
Temsirolimus + everolimus ? $ B! {) h9 [& N' ~! r" [
————————————————————
% y: y4 J& [3 A†Led to US FDA warning.
9 q+ D3 D O( z" j8 t, z?: As yet unattempted combination.
- _$ D) s; ]- D" Z |